Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) ROCE % : 18.21% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Sichuan Goldstone Asia Pharmaceutical's annualized ROCE % for the quarter that ended in Mar. 2024 was 18.21%.

Sichuan Goldstone Asia Pharmaceutical ROCE % Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical ROCE % Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

5.70

-26.57

4.26

12.57

7.28

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															30.18	1.17	-2.88	0.55	18.21

Sichuan Goldstone Asia Pharmaceutical ROCE % Calculation

Sichuan Goldstone Asia Pharmaceutical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	177.689	/	( ( (3059.913 - 677.585)	+	(3101.439 - 601.172) )	/ 2 )
	=	177.689	/	( (2382.328	+	2500.267)	/ 2 )
	=	177.689	/	2441.2975
	=	7.28 %

Sichuan Goldstone Asia Pharmaceutical's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	463.208	/	( ( (3101.439 - 601.172)	+	(3105.395 - 517.898) )	/ 2 )
	=	463.208	/	( ( 2500.267	+	2587.497 )	/ 2 )
	=	463.208	/	2543.882
	=	18.21 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Sichuan Goldstone Asia Pharmaceutical ROCE % Related Terms

Thank you for viewing the detailed overview of Sichuan Goldstone Asia Pharmaceutical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072

Website

http://www.goldstone-group.com

Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines